Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia
- 1 September 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 31 (9), 2212-2217
- https://doi.org/10.1161/01.str.31.9.2212
Abstract
Background and Purpose—Pretreatment with intraventricular brain-derived neurotrophic factor (BDNF) reduces ischemic damage after focal cerebral ischemia. In this experiment we studied the effect of...Keywords
This publication has 36 references indexed in Scilit:
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 1995
- Basic Fibroblast Growth Factor Protects against Excitotoxicity and Chemical Hypoxia in Both Neonatal and Adult RatsJournal of Cerebral Blood Flow & Metabolism, 1995
- Role of Bcl‐2 in the Brain‐derived Neurotrophic Factor Survival ResponseEuropean Journal of Neuroscience, 1995
- Temporal Profile of in situ DNA Fragmentation after Transient Middle Cerebral Artery Occlusion in the RatJournal of Cerebral Blood Flow & Metabolism, 1995
- BDNF‐activated Sianal Transduction in Rat Cortical Glial CellsEuropean Journal of Neuroscience, 1995
- Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neuronsExperimental Neurology, 1995
- Brain‐derived Neurotrophic Factor is a Survival Factor for Cultured Rat Cerebellar Granule Neurons and Protects them Against Glutamate‐induced NeurotoxicityEuropean Journal of Neuroscience, 1993
- trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3Cell, 1991
- The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth FactorScience, 1991